What caused today’s spike in B8F.DE stock and should I trade it?

Intraday volume and price prints show a jump to **€6.804** with **45,797** shares traded. No confirmed company release is required for such moves. Trading is possible but risky; use tight risk controls, small sizes and confirm sustained volume before holding overnight.

What is Meyka AI’s short-term view and forecast for B8F.DE stock?

Meyka AI's model gives a 12‑month target of **€8.50**, implying **24.93%** upside from **€6.804**. The platform flags elevated volatility and the projection is a model estimate, not a guarantee. Monitor fundamentals and regulatory news.

How do Biofrontera’s fundamentals compare within the Healthcare sector for B8F.DE stock?

Biofrontera shows weaker scale: negative EPS **-0.21**, high price-to-book **21.73**, but low EV/EBITDA **3.36**. Sector peers typically have larger caps and steadier margins, so Biofrontera carries greater small-cap and execution risk.

Is liquidity adequate to enter or exit a position in B8F.DE stock?

Today’s liquidity surged to **45,797** shares, far above the average **605**, creating tradable size intraday. Outside event days liquidity is limited; aim for limit orders and expect larger spreads when volume reverts.

DE Stocks

B8F.DE Biofrontera AG XETRA €6.804 intraday jump 28 Jan 2026: watch volume

ByHuzaifa Zahoor January 28, 2026

The B8F.DE stock surged intraday to €6.804 on XETRA on 28 Jan 2026 on heavy volume, marking a sharp re-rating from the open at €0.368 and previous close €0.324. Volume hit 45,797 vs average 605, a relative volume of 75.70x, making Biofrontera AG a top high-volume mover in Germany today. Traders and analysts are watching liquidity and valuation after this volatile move. We examine drivers, key ratios, risks and a model-based forecast to help frame intraday trading and short-term positioning.